Healthcare resource utilization among commercially insured patients with cold agglutinin disease in the United States

被引:8
|
作者
Su, Jun [1 ]
Bylsma, Lauren C. [2 ]
Jiang, Xiaohui [2 ]
Morales Arias, Jaime [1 ]
Jain, Nisha [1 ]
Nordyke, Robert J. [3 ]
机构
[1] Sanofi, 50 Binney St, Cambridge, MA 02142 USA
[2] EpidStrategies, Ann Arbor, MI USA
[3] Beta6 Consulting Grp, Los Angeles, CA USA
关键词
Disease burden; healthcare resource utilization; cold agglutinin disease; autoimmune hemolytic anemia; database analysis; BURDEN; ANEMIA; COSTS;
D O I
10.1080/13696998.2020.1764006
中图分类号
F [经济];
学科分类号
02 ;
摘要
Aims: Cold agglutinin disease (CAD) is a rare subtype of autoimmune hemolytic anemia associated with increased thromboembolism risk and early mortality. Healthcare resource utilization (HRU) in CAD has not been reported. We aimed to compare HRU of patients with CAD with a matched non-CAD cohort in the United States. Materials and methods: Patients with CAD were identified from 2006 to 2016 in the Optum-Humedica database using CAD terms in clinical notes and hematologist review. Patients were required to have Integrated Delivery Network records and >= 6 months' follow-up before and after the first CAD mention date (index date). Patients with CAD were matched to a non-CAD cohort based on demographics. Multivariate analyses assessed inpatient hospitalizations, outpatient visits, emergency room visits, and transfusion use between cohorts 6 months before and 12 months after the index date. Results: Of 814 patients with CAD, 410 met inclusion criteria and were matched to 3,390 patients without CAD. Mean age of patients with CAD was 68.0 years; approximately 62% were female. In the 12 months after the index date, mean inpatient hospitalizations (0.83 vs. 0.25), outpatient visits (17.26 vs. 6.77), emergency room visits (0.55 vs. 0.32), and transfusion days (1.05 vs. 0.05) were higher for patients with CAD than the matched non-CAD cohort (all p < .0001). Similarly, in the 6 months before the index date, patients with CAD had higher HRU than matched patients without CAD for all measures evaluated. Limitations: Results of this study are based on patient information from the Optum-Humedica database, which is limited to commercially insured patients and may not represent the overall CAD population. Conclusions: CAD places a substantial burden on patients and healthcare systems. In addition, the high HRU for patients with CAD observed in the 6 months before diagnosis indicates that disease awareness and better diagnostic practices may be needed.
引用
收藏
页码:902 / 907
页数:6
相关论文
共 50 条
  • [41] Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States
    Marc A Riedl
    Aleena Banerji
    Michael E Manning
    Earl Burrell
    Namita Joshi
    Dipen Patel
    Thomas Machnig
    Ming-Hui Tai
    Douglas J Watson
    Orphanet Journal of Rare Diseases, 13
  • [42] Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States
    Riedl, Marc A.
    Banerji, Aleena
    Manning, Michael E.
    Burrell, Earl
    Joshi, Namita
    Patel, Dipen
    Machnig, Thomas
    Tai, Ming-Hui
    Watson, Douglas J.
    ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
  • [43] Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States
    Bonafede, Machaon
    Sapra, Sandhya
    Shah, Neel
    Tepper, Stewart
    Cappell, Katherine
    Desai, Pooja
    HEADACHE, 2018, 58 (05): : 700 - 714
  • [44] The impact of high-risk and chronic opioid use among commercially insured endometriosis patients on health care resource utilization and costs in the United States
    Estes, Stephanie J.
    Soliman, Ahmed M.
    Zivkovic, Marko
    Chopra, Divyan
    Zhu, Xuelian
    WOMENS HEALTH, 2020, 16
  • [45] HEALTH CARE RESOURCE UTILIZATION AND COSTS AMONG PATIENTS WITH ESSENTIAL TREMOR: A RETROSPECTIVE OBSERVATIONAL STUDY IN A UNITED STATES COMMERCIALLY INSURED AND MEDICARE ADVANTAGE POPULATION
    Dai, D.
    Fernandes, J.
    Samiian, A.
    Coetzer, H.
    VALUE IN HEALTH, 2021, 24 : S161 - S161
  • [46] HEALTHCARE RESOURCE UTILIZATION AMONG ALZHEIMER'S DISEASE PATIENTS USING ANTIHYPERTENSIVE MEDICATION IN UNITED STATES AND FRANCE
    Wing, V. K.
    Buderi, R.
    Vigna, C.
    Rusli, E.
    Jain, R.
    Galaznik, A.
    VALUE IN HEALTH, 2020, 23 : S639 - S639
  • [47] Measuring Healthcare Delays Among Privately Insured Patients in the United States
    El Halabi, J.
    Palmer, N. P.
    Fox, K.
    Golub, J. E.
    Kohane, I.
    Farhat, M. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [48] Excess healthcare resource utilization and healthcare costs among privately and publicly insured patients with major depressive disorder and acute suicidal ideation or behavior in the United States
    Zhdanava, Maryia
    Voelker, Jennifer
    Pilon, Dominic
    Joshi, Kruti
    Morrison, Laura
    Sheehan, John J.
    Vermette-Laforme, Maude
    Lefebvre, Patrick
    Citrome, Leslie
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 311 : 303 - 310
  • [49] Naloxone dispensing among the commercially insured population in the United States
    Dunphy, Christopher
    Zhang, Kun
    Guy, Gery P., Jr.
    Jones, Christopher M.
    PREVENTIVE MEDICINE, 2021, 153
  • [50] HEALTHCARE BURDEN AND UTILIZATION AMONG PATIENTS HOSPITALIZED WITH LIVER DISEASE IN THE UNITED STATES
    Rajpal, Neha
    Fansiwala, Kush
    Khan, Sameer
    Kim, Amy
    Limketkai, Berkeley N.
    Chen, Po-Hung
    GASTROENTEROLOGY, 2022, 162 (07) : S1142 - S1143